CEACAM8 and melanoma: Stages I and II melanoma-derived neutrophils showed significantly higher CD66b expression than neutrophils obtained from healthy donors and by trend a higher expression compared to neutrophils from late-stage melanoma patients (p = 0.09) (Supplementary Figure S2B).